Prosecution Insights
Last updated: October 04, 2026

Casimir Jones, S.C.

Technology area: Biotechnology & Pharmaceuticals

355 pending office actions • 150 clients • 294 examiners • 108 art units • 0 of 355 (0%) have an AI response strategy ready

Analysis

Casimir Jones, S.C. manages 11096 career applications in the Biotechnology & Pharmaceuticals technology area. The firm is currently addressing 301 pending office actions. Its resolved allowance rate is 80.73 percent.

The firm averages 4.16 office actions per allowance. This metric reflects the iterative nature of the prosecution process in the life sciences. For practitioners, the 80.73 percent allowance rate and the 4.16 average office actions per allowance offer a benchmark for the expected success and the number of procedural steps required to secure biotechnology and pharmaceutical patents.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=11096 apps, methodology: how we score firms)

80.7%
Allowance Rate
n=11096
+0.76σ
Allowance Rate (norm)
n=11096
4.2
OAs to Allowance
n=5041
+0.02σ
OAs to Allow (norm)
n=5041
1123 days
Time to Allowance
n=5041
+16.1pp
Interview Lift
n=11096
39.0%
RCE Rate
n=11096
1.4%
Appeal Rate
n=11096

Rejection Performance (% of received rejections ultimately overcome)

73.8%
§101 Overcome
n=973
69.1%
§102 Overcome
n=2768
69.6%
§103 Overcome
n=3986
73.9%
§112 Overcome
n=4083

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
32%
Top-3 CPC Share
n=11096
10
Practitioners
n=11096
1109.6
Apps / Practitioner
n=11096

Portfolio Summary

355
Total Pending OAs
236
Non-Final OAs
112
Final Rejections
7
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 110 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

49
Overdue
4
Due this week
33
Due this month
19
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 110 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (49)Due ≤ 7 days (4)Due ≤ 30 days (33)Due ≤ 60 days (19)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

176
Hard (50%)
140
Medium (39%)
37
Easy (10%)
2
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only4 (1%)
§101 + other44 (12%)
§103 only89 (25%)
§102 only13 (4%)
§112 only25 (7%)
Double-patenting only12 (3%)
Double-patenting + other38 (11%)
Multi-statute (no §101)128 (36%)
No statute on record2 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

250
Life Sciences
70% of docket
1
Information Tech
0% of docket
3
Communications
1% of docket
4
Semiconductors
1% of docket
37
Mechanical / Eng
10% of docket
60
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

3,550 h
Manual time on pending OAs
710 h
Time saved (low, 20%)
1,242 h
Time saved (mid, 35%)
31.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SALMON, KATHERINE D 5 42.8% +37.9%
EBBINGHAUS, BRIANA NOEL 4 61.6% +63.5%
MIANO, JOSEPH PAUL 3 36.0% +63.3%
SU, STEPHANIE T 3 67.1% +29.4%
CHUNDURU, SURYAPRABHA 3 53.3% +17.8%
HINES, JANA A 3 53.0% +39.7%
MAHLUM, JONATHAN DAVIS 3 51.4% +25.6%
GOLDBERG, JEANINE ANNE 3 45.8% +40.8%
LEE, CHIHYI NMN 3 33.7% +60.8%
DABKOWSKI, ERINNE R 3 55.9% +69.0%

Hard Cases (176)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17923671 FLUID INJECTION DEVICE FOR INJECTING A FLUID BEHIND THE TYMPANIC MEMBRANE DAVIS, JASON GREGORY 167d overdue
17920698 INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF BRADLEY, CHRISTINA 162d overdue
17768274 COMPOUNDS FOR IMMUNOMODULATION MIANO, JOSEPH PAUL 146d overdue
17906471 T-CELL BISPECIFIC BINDING PROTEINS OGUNBIYI, OLUWATOSIN A 126d overdue
17764850 IgE Antibody with Fcgamma Receptor binding SANG, HONG 100d overdue
17630568 ELECTRONIC HAIL PAD ISLAM, MOHAMMAD K 89d overdue
17929809 METHODS AND SYSTEMS FOR PROCESSING TIME-RESOLVED SIGNAL INTENSITY DATA CROW, ROBERT THOMAS 51d overdue
17549028 PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE ZHU, JIANJIAN 44d overdue

Interview Candidates (33)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17768274 COMPOUNDS FOR IMMUNOMODULATION MIANO, JOSEPH PAUL 146d overdue
18425731 PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS HINES, JANA A 119d overdue
17727128 DETECTING ESOPHAGEAL DISORDERS GOLDBERG, JEANINE ANNE 104d overdue
18313856 COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS DABKOWSKI, ERINNE R 37d overdue
18004082 BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF HINES, JANA A 36d overdue
18245660 METHODS AND COMPOSITIONS FOR REMOVAL OF RNA SALMON, KATHERINE D 5d overdue
17266897 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS DABKOWSKI, ERINNE R 2d overdue
18003807 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION LEE, CHIHYI NMN 6d

Client Portfolio (150 clients)

Client (Assignee)Pending OAs
University of Michigan 42
Northwestern University 17
Abbott Laboratories 15
THE CLEVELAND CLINIC FOUNDATION 11
University of Arizona 10
Cavh 9
University of Chicago 9
North Carolina State University 9
Exact Sciences 8
Promega Corporation 8
Stanford University 8
Duke University 6
Columbia University 6
Arla Foods 5
NANYANG TECHNOLOGICAL UNIVERSITY 5
Mayo Clinic 5
SHINE Technologies, LLC 4
UNIVERSITY OF MARYLAND, BALTIMORE 4
Invibio 4
UMBC 4
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS 4
GT METABOLIC SOLUTIONS, INC. 3
Danmarks Tekniske Universitet 3
Arizona State University 3
Bayer 3
Arc Boat 3
CRISPR Therapeutics 3
Tokuyama 3
Osaka University 2
GEN-PROBE INCORPORATED 2
Geltor 2
Immunexpress Pty Ltd. 2
Johns Hopkins 2
ACADEMISCH ZIEKENHUIS MAASTRICHT 2
Aker BioMarine 2
Colorado State University 2
Amgen 2
ADMINISTRACIÓN GENERAL DE LA COMUNIDAD AUTÓNOMA DE EUSKADI 2
Flambeau 2
UNC Chapel Hill 2
Riken 2
IOGENETICS, LLC 2
Spiderwort Inc. 2
ADVANCED CELL DIAGNOSTICS, INC. 2
TU Eindhoven 2
Zhaotai Immugene 2
Fixed Phage Limited 2
Leo Cancer Care, Inc. 1
UMC UTRECHT HOLDING B.V. 1
Evity Technologies, Inc. 1
OKAMOTO CORPORATION 1
P-Vine, Inc. 1
Luminoah 1
Johnson & Johnson 1
Consejo Superior de Investigaciones Científicas 1
Printer Tailored, LLC 1
SOFTBANK CORP. 1
PRODRUGXTEND PTY LTD 1
REGENTS OF THE UNIVERSITY OF MINNESOTA 1
Accure Medical, LLC 1
Venus Aerospace Corp. 1
Trizell Ltd. 1
THE UNIVERSITY OF BIRMINGHAM 1
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA 1
Ludwig Institute 1
Ferring International Center S.A. 1
Nanomik Biyoteknoloji Anonim Sirketi 1
Lumicks 1
Vlp Biotech, Inc. 1
Thermochem, Inc. 1
Japan Brain Corporation 1
Genodx Pty Ltd. 1
Exebenus AS 1
Farmalíder, S.A. 1
Hunilife Biotechnology, Inc. 1
STELLENBOSCH UNIVERSITY 1
University of Melbourne 1
Pusan National University Industry-university Cooperation Foundation 1
NEGATIVE EMISSIONS MATERIALS, INC. 1
Fundación Para La Investigación Del Hospital Clínico De La Comunidad Valenciana 1
Fuji Seal 1
Elephas Biosciences 1
The Catholic University Of Korea Industry Academic Cooperation Foundation 1
ADVANCED MATERIAL DEVELOPMENT LIMITED 1
Tocris Cookson Limited 1
University of Connecticut 1
Enduro Genetics Aps 1
ACRIGEN BIOSCIENCES 1
Comell University 1
UPPTHERA 1
CATALENT PHARMA SOLUTIONS, LLC 1
Abbott Laboratories 1
Elixiron Immunotherapeutics (Hong Kong) Limited 1
Cornell University 1
R&D Systems, Inc. 1
Jiangsu Richen-Bases Bio & Sci Co., Ltd. 1
NUCLEIN, LLC 1
UNIVERSIDAD DE NAVARRA 1
UNIVERSITY OF ROCHESTER 1
Queen Mary University London 1
PLATELET TARGETED THERAPEUTICS, LLC 1
Northwestem University 1
MIT 1
Asthra, LLC 1
NATIONAL INSTITUTES OF HEALTH 1
Glen Clova Scientific Limited 1
Moresco 1
Catholic University of Korea 1
RIGSHOSPITALET 1
East China Normal University 1
TrueTrace Biometrics, Inc. 1
Kdc/One Development Corporation, Inc. 1
Emory University 1
Covirix Medical Pty Ltd. 1
Ksb Tugen Inc. 1
PALOBIOFARMA, S.L. 1
SMARTFLOW TECHNOLOGIES, INC. 1
NCARDIA B.V. 1
University of Utah 1
THE ROSALIND FRANKLIN INSTITUTE 1
UNIVERSIDAD DE GRANADA 1
Northern Sydney Local Health District 1
R-NANOBIO CO. LTD. 1
The Brigham and Women's Hospital Inc. 1
Purdue University 1
University of California 1
Centro De Investigaciones Energéticas Medioambientales Y Tecnológicas, O.A.M.P. (Ciemat) 1
Jina Pharmaceuticals 1
BOGAZICI UNIVERSITESI 1
UNIVERSITY OF OTTAWA 1
NASASBIOTECH, S.L. 1
IDIBELL 1
Epsilogen Ltd 1
BLACKROCK MICROSYSTEMS, LLC dba 1
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION 1
Understory, Inc. 1
Lifescience AS 1
Kyungpook National University 1
TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE 1
Liv Innovation SA 1
King's College London 1
Austin Research Labs 1
Engineering Arts LLC 1
Regenics AS 1
Ibmc - Instituto De Biologia Molecular E Celular 1
MD ORTHO SYSTEMS LLC 1
ILC THERAPEUTICS LIMITED 1
LMU Klinikum 1
TWO CELLS Co., Ltd. 1
IMBED Biosciences 1

Top Art Units

Art UnitApps
168215
16819
16759
16439
16838
16318
16327
16417
16547
16576

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19426765 PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES Arla Foods Amba TRAN, LIEN THUY 1793 §103§112DP Non-Final OA — Pending Dec 19, 2025
19374947 COMPOSITIONS AND METHODS FOR OBTAINING HUMAN INTESTINAL TISSUE AND RELATED USES THEREOF The Regents of the University of Michigan BERTOGLIO, VALARIE E 1632 DP Final Rejection — Pending Oct 30, 2025
19161361 PATIENT SUPPORT BOARD Leo Cancer Care, Inc. PATEL, TARLA R 3786 §102§103 Non-Final OA — Pending Sep 02, 2025
19259714 HUMAN SPINAL CORD INJURY ORGANOIDS Northwestern University EBBINGHAUS, BRIANA NOEL 1632 §101§102§103§112DP Non-Final OA — Pending Jul 03, 2025
19233435 LOCALIZED GENERATIVE ARTIFICIAL INTELLIGENCE FOR AUTONOMOUS DRIVING WITH WORLD MODEL Cavh LLC MARTINEZ BORRERO, LUIS A Other Non-Final OA — Pending Jun 10, 2025
19231650 RESTORATION AND ELEVATION FOR VEHICLE DRIVING INTELLIGENCE Cavh LLC REDHEAD JR., ASHLEY L §103 Non-Final OA — Pending Jun 09, 2025
19226996 ANASTOMOSIS FORMATION WITH MAGNETIC DEVICES HAVING TEMPORARY RETENTION MEMBER Gt Metabolic Solutions, Inc. DAVID, SHAUN L 3771 §103§112DP Non-Final OA — Pending Jun 03, 2025
19128886 COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING A DNA MODIFICATION UMC Utrecht Holding B.V. TOKARCZYK, CHRISTOPHER B 3687 §102§103§112 Non-Final OA — Pending May 09, 2025
19177062 INCENTIVIZATION SYSTEMS FOR CURATION OF ARTIFICIAL INTELLIGENCE SYSTEMS Evity Technologies, Inc. PATEL, DIVESH 3696 §101§102§103 Non-Final OA — Pending Apr 11, 2025
19175167 DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS Gt Metabolic Solutions, Inc. TANNER, JOCELIN C §102§103Other Non-Final OA — Pending Apr 10, 2025
19119530 KNITTED FABRIC AND ATTACHMENT USING SAID KNITTED FABRIC Okamoto Corporation HUANG, GRACE 3732 §102§103 Final Rejection — Pending Apr 09, 2025
19113074 DUAL SCINTILLATOR SYSTEM FOR NEUTRON AND ELECTROMAGNETIC IMAGING Shine Technologies, LLC KAO, CHIH CHENG G 2884 §102§103§112 Non-Final OA — Pending Mar 19, 2025
19112886 METHODS, DEVICES, AND SYSTEMS FOR TREATING BONE DEFECTS The Regents of the University of Michigan LAWSON, MATTHEW JAMES 3619 §102§103 Non-Final OA — Pending Mar 18, 2025
19108219 PHOTOCLEAVAGE OF INDICAN Danmarks Tekniske Universitet KHAN, AMINA S §101§102§103§112 Non-Final OA — Pending Mar 03, 2025
19065311 PROACTIVE SENSING SYSTEMS FOR AUTOMATED DRIVING SYSTEMS Cavh LLC POPE, DARYL C DP Non-Final OA — Pending Feb 27, 2025
19057621 CLOUD-BASED AUTOMATED DRIVING SYSTEM FOR ADVERSE WEATHER CONDITIONS Cavh LLC EL CHANTI, HUSSEIN A 3669 DP Final Rejection — Pending Feb 19, 2025
18998013 RECORD SUPPORT PLATE, RECORD JACKET, AND RECORD PRODUCT P-Vine, Inc. KLIMOWICZ, WILLIAM JOSEPH 2688 §102§103 Non-Final OA — Pending Jan 23, 2025
19030131 SYSTEM AND METHOD FOR SINGLE MOLECULE DETECTION Arizona Board of Regents NOGUEROLA, ALEXANDER STEPHAN §103§112Other Non-Final OA — Pending Jan 17, 2025
19022747 DEVICES AND METHODS FOR ASSISTING MAGNETIC COMPRESSION ANASTOMOSIS Gt Metabolic Solutions, Inc. TANNER, JOCELIN C 3771 §102 Final Rejection 78d overdue Pending Jan 15, 2025
18994414 COMPOSITIONS AND METHODS FOR GROWING ESOPHAGEAL CELLS AND RELATED USES THEREOF The Regents of the University of Michigan MIANO, JOSEPH PAUL §101§102§103§112 Non-Final OA — Pending Jan 14, 2025
19020225 VEHICLE SAFETY SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103 Final Rejection — Pending Jan 14, 2025
19019000 VEHICLE-BASED CLOUD COMPUTING SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103 Final Rejection — Pending Jan 13, 2025
19016469 NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF BAYER AKTIENGESELLSCHAFT RAMIREZ, DELIA M 1652 §102§103 Non-Final OA — Pending Jan 10, 2025
19011131 VEHICLE COMPUTING SYSTEM FOR AUTONOMOUS DRIVING Cavh LLC SU, STEPHANIE T 3662 §103§112 Final Rejection — Pending Jan 06, 2025
19008900 BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS UNIVERSITY OF MARYLAND, BALTIMORE WAX, ROBERT A §102§103§112 Non-Final OA — Pending Jan 03, 2025
18990320 SEPARABLE BI-DIRECTIONAL CHECK VALVE ASSEMBLY Luminoah, Inc. COLON MORALES, DAVID 3753 §103 Final Rejection 27d Pending Dec 20, 2024
18987112 GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY Abbott Laboratories FARDANESH, MARJAN §102 Non-Final OA — Pending Dec 19, 2024
18984183 GAS JET DEFLECTION IN PRESSURIZED SYSTEMS Shine Technologies, LLC WILLIAMS, JOSEPH L §112 Non-Final OA — Pending Dec 17, 2024
18873153 OPTICAL ELEMENT Osaka University LAVARIAS, ARNEL C 2872 §102§103 Non-Final OA — Pending Dec 09, 2024
18971607 LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS The University of Chicago HADDAD, MAHER M §103§112 Non-Final OA — Pending Dec 06, 2024
18867262 VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER The University of Chicago CONIGLIO, AUDREA JUNE BUCKLEY §103§112 Non-Final OA — Pending Nov 19, 2024
18943512 FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD Exact Sciences Corporation BROWN, MINDY G 1683 §112 Non-Final OA 45d overdue Pending Nov 11, 2024
18941862 BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE Northwestern University ZHU, JIANJIAN 1631 §103 Non-Final OA — Pending Nov 08, 2024
18863903 CONTACT LENS PACKAGES AND LENS SUPPORTS FOR USE THEREIN Johnson & Johnson Vision Care, Inc. OJOFEITIMI, AYODEJI HARRY 3651 §103§112 Non-Final OA — Pending Nov 07, 2024
18939319 TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING Gen-Probe Incorporated CHUNDURU, SURYAPRABHA 1681 §103 Non-Final OA — Pending Nov 06, 2024
18938794 COMPOSITIONS AND METHODS RELATED TO SOMATIC EMBRYOGENESIS IN ROSE PLANTS North Carolina State University KAY, ZACHARIAH A 1661 §102§103§112 Non-Final OA — Pending Nov 06, 2024
18862189 ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS BURKETT, DANIEL JOHN §102§112 Non-Final OA — Pending Nov 01, 2024
18929268 METHODS AND SYSTEMS RELATING TO ARTIFICIAL INTELLIGENCE FOR EARLY RECOGNITION OF RARE SKIN DISEASES Northwestern University BOYAR, NOAH WILLIAM §101§103§112 Non-Final OA — Pending Oct 28, 2024
18859007 LIPIDS, FORMULATIONS, AND USES THEREOF The Regents of the University of Michigan CHANDRAKUMAR, NIZAL S §102§103§112 Non-Final OA — Pending Oct 22, 2024
18921114 CUSTOMIZED, WEARABLE 3D PRINTED ARTICLES AND METHODS OF MANUFACTURING SAME Printer Tailored, LLC YANCHUS III, PAUL B DP Non-Final OA — Pending Oct 21, 2024
18919564 USE OF MULTIPHOTON EXCITATION FOR FLUORESCENCE IMAGING OF STAINED CALCIFIED MINERALS UNIVERSITY OF MARYLAND, BALTIMORE MOSHER, ERIC PARKER §103DP Non-Final OA — Pending Oct 18, 2024
18852916 TRANS-VACCENIC ACID (TVA) AND DERIVATIVES THEREOF IN T CELL-BASED CANCER THERAPIES The University of Chicago MCANANY, JOHN D §102§103§112 Non-Final OA — Pending Sep 30, 2024
18849659 VEHICLE AND SERVER Softbank Corp. PALL, CHARLES J 3663 §103 Non-Final OA — Pending Sep 23, 2024
18884534 ACIDIC BETA-LACTOGLOBULIN BEVERAGE PREPARATION Arla Foods Amba TAYLOR, AUSTIN PARKER §103§112Other Non-Final OA — Pending Sep 13, 2024
18844878 METHODS AND COMPOSITIONS FOR PRODUCING TOBACCO PLANTS WITH REDUCED NICOTINIC ALKALOID LEVELS North Carolina State University KUMAR, VINOD 1663 §101§102§103§112Other Non-Final OA — Pending Sep 06, 2024
18823760 NOVEL FORMULATION AND TREATMENT METHODS Prodrugxtend Pty Ltd. FAY, ZOHREH ALEMZADEH 1617 §101DP Non-Final OA 31d overdue Pending Sep 04, 2024
18818917 MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME Regents Of The University Of Minnesota KELLY, ROBERT M §102§112 Non-Final OA — Pending Aug 29, 2024
18816319 SYSTEMS AND METHODS FOR TREATMENT OF FUNGUS Accure Medical, LLC SMITH, KAITLYN ELIZABETH 3794 §103 Final Rejection — Pending Aug 27, 2024
18812371 ENHANCEMENT OF KINASE TARGET ENGAGEMENT Promega Corporation STEADMAN, DAVID J 1656 §103DPOther Non-Final OA — Pending Aug 22, 2024
18840007 ARTIFICIAL SERTOLI CELLS AND METHOD FOR THEIR PRODUCTION The Regents of the University of Michigan MIANO, JOSEPH PAUL §102§103§112 Non-Final OA — Pending Aug 20, 2024
18809157 METHOD, APPARATUS AND COMPOSITION FOR PROPULSION GRADE HYDROGEN PEROXIDE HEAVY IN-ORGANIC STABILIZATION USE IN ROTATING DETONATING ROCKET ENGINES & LONG-TERM STORAGE IN PROPELLANT MANAGEMENT SYSTEMS Venus Aerospace Corp. THOMAS, KYLE ROBERT 3741 §102§103§112 Non-Final OA — Pending Aug 19, 2024
18804255 VIRAL VECTOR STABILIZATION Trizell Ltd. SALVOZA, M FRANCO G §102DP Non-Final OA — Pending Aug 14, 2024
18838225 GENERATING BONE MARROW ORGANOIDS The University of Birmingham BERKE-SCHLESSEL, DAVID W §102§103 Non-Final OA — Pending Aug 13, 2024
18836472 MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE UNIVERSIDADE DE SANTIAGO DE COMPOSTELA GULLEDGE, BRIAN M §103 Non-Final OA — Pending Aug 07, 2024
18796015 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents SCHMITT, MICHAEL J DP Non-Final OA — Pending Aug 06, 2024
18781157 BISULFITE-FREE, BASE-RESOLUTION IDENTIFICATION OF CYTOSINE MODIFICATIONS LUDWIG INSTITUTE FOR CANCER RESEARCH LTD RILEY, JEZIA §103Other Non-Final OA — Pending Jul 23, 2024
18775012 ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS Northwestern University DAVIS, RUTH A §102Other Non-Final OA — Pending Jul 17, 2024
18728654 A MOULD TOOL Invibio Device Component Manufacturing Limited DERUSSO, JOHN J 1744 §102§103 Final Rejection 19d Pending Jul 12, 2024
18728665 A COMPRESSION MOULDED BODY Invibio Device Component Manufacturing Limited SIMONE, CATHERINE A 1781 §102 Non-Final OA — Pending Jul 12, 2024
18769686 METHODS OF PRODUCING RECOMBINANT ADENOVIRUS VECTORS Ferring International Center S.A. WANG, RUIXUE 1672 §102§103§112 Non-Final OA — Pending Jul 11, 2024
18768722 ARTIFICIAL INTELLIGENCE-BASED MOBILE ROADSIDE INTELLIGENT UNIT AND EDGE COMPUTING UNIT FOR AUTONOMOUS DRIVING Cavh LLC SHERWIN, RYAN W 2688 §103 Non-Final OA — Pending Jul 10, 2024
18766065 LATERAL FLOW METHODS, ASSAYS, AND DEVICES FOR DETECTING THE PRESENCE OR MEASURING THE AMOUNT OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 AND/OR GLIAL FIBRILLARY ACIDIC PROTEIN IN A SAMPLE Abbott Laboratories HAQ, SHAFIQUL §102§103DP Non-Final OA — Pending Jul 08, 2024
18726901 MICROENCAPSULATED ESSENTIAL OILS Nanomik Biyoteknoloji Anonim Sirketi ROSSI, JULIA ANNE LORRAIN 1615 §101§102§103§112 Non-Final OA — Pending Jul 05, 2024
18764956 Apparatus or Method for Determining Blood Pressure of a Subject Nanyang Technological University FARAG, AMAL ALY 3798 §103 Final Rejection 34d Pending Jul 05, 2024
18761704 HIGH POWER ION BEAM GENERATOR SYSTEMS AND METHODS Shine Technologies, LLC WASIL, DANIEL D §103§112 Non-Final OA — Pending Jul 02, 2024
18761632 ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS Abbott Point Of Care Inc. HOFFMAN, ALEXANDER JOSEPH §103 Non-Final OA — Pending Jul 02, 2024
18725439 SELECTING FORCES FOR MEANS AND METHODS INVOLVING CELLULAR AVIDITY Lumicks Ca Holding B.V. KELLY, ROBERT M 1657 §112 Non-Final OA — Pending Jun 28, 2024
18750919 RECOMBINANT COLLAGEN AND ELASTIN MOLECULES AND USES THEREOF Geltor, Inc. KOMATSU, LI N 1658 §101§102§112DP Non-Final OA — Pending Jun 21, 2024
18721830 ACOUSTICALLY-RESPONSIVE BIOINKS FOR EXTRUSION-BASED 3D-BIOPRINTING The Regents of the University of Michigan STEINKE, SEAN JAMES 1619 §102§103§112Other Non-Final OA — Pending Jun 19, 2024
18746198 DETECTING NEOPLASM Mayo Foundation for Medical Education and Research AEDER, SEAN E §101§112DP Non-Final OA — Pending Jun 18, 2024
18744995 DETECTION OF COLON NEOPLASIA BY ANALYSIS OF METHYLATED DNA Mayo Foundation for Medical Education and Research GREENE, CAROLYN LEE §101 Non-Final OA — Pending Jun 17, 2024
18735858 HUMAN SPINAL CORD INJURY ORGANOIDS Northwestern University EBBINGHAUS, BRIANA NOEL 1632 §102§103§112 Non-Final OA — Pending Jun 06, 2024
18732175 MULTIPLEX AMPLIFICATION DETECTION ASSAY Exact Sciences Corporation PRIEST, AARON A DP Final Rejection — Pending Jun 03, 2024
18715507 IMMUNOGENS TARGETING ANTHRAX Vlp Biotech, Inc. DICKENS, AMELIA NICOLE 1645 §101§102§103§112 Non-Final OA — Pending May 31, 2024
18675612 GENERATING HUMAN PODOCYTE CELLS The Cleveland Clinic Foundation MONTANARI, DAVID A §101 Non-Final OA — Pending May 28, 2024
18671569 GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION BAYER AKTIENGESELLSCHAFT HUDSON, AMY ROSE §103§112 Non-Final OA — Pending May 22, 2024
18666426 STATIC MIXER ASSEMBLY FOR pH-MODIFICATION IN GEOTHERMAL POWER PLANTS Thermochem, Inc. HOWELL, MARC C §103 Non-Final OA — Pending May 16, 2024
18710932 IRRADIATION DEVICE AND IRRADIATION METHOD Osaka University CONLON, MARISA V 3643 §103§112 Final Rejection 62d Pending May 16, 2024
18661922 FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES UNIVERSITY OF MARYLAND, BALTIMORE SHIAO, REI TSANG 1629 §112DP Non-Final OA — Pending May 13, 2024
18657413 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION The Regents of the University of Michigan CLARKE, TRENT R 1651 §103 Non-Final OA — Pending May 07, 2024
18708092 DGAT1/2-INDEPENDENT ENZYME SYNTHESIZING STORAGE LIPIDS (DIESL) Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis JACKSON III, WALTER §102§103§112 Non-Final OA — Pending May 07, 2024
18707971 Compositions and Methods for Modulating the Effect of Beta-Blocker Activity in a Subject Duke University MOU, LIYUAN §103§112 Non-Final OA — Pending May 07, 2024
18654067 VIRTUAL GOLF SYSTEM AND MANAGEMENT DEVICE Japan Brain Corporation HU, KANG 3715 §101§102 Non-Final OA — Pending May 03, 2024
18655005 COMPLEMENTATION-BASED TAGS AND REPORTERS FOR DUAL-MODALITY LABELING Promega Corporation BOWERS, ERIN M 1653 §103§112 Non-Final OA — Pending May 03, 2024
18705695 COMPOSITIONS AND METHODS FOR DETECTING OROPHARYNGEAL CANCER Mayo Foundation for Medical Education and Research WOOLWINE, SAMUEL C 1637 §102§103§112 Non-Final OA — Pending Apr 29, 2024
18705818 BIOMARKERS AND USES THEREFOR Genodx Pty Ltd. MYERS, CARLA J 1682 DP Non-Final OA — Pending Apr 29, 2024
18645058 Radiation Effects Testing System with a Beam Accelerator Shine Technologies, LLC WANG, JING 3646 §102§103 Non-Final OA — Pending Apr 24, 2024
18644245 SYSTEMS AND METHODS OF FLOODING A WATERCRAFT BATTERY Arc Boat Company FIX, THOMAS S 3618 §102§103 Non-Final OA — Pending Apr 24, 2024
18640956 CONDUCTIVE ELASTOMER FOR BLADDER REGENERATION Northwestern University WEBB, WALTER E 1612 §102§103 Non-Final OA — Pending Apr 19, 2024
18640898 PHYSICS-INCORPORATED TURBINE BLADE PITCH CONTROL TECHNOLOGY UNIVERSITY OF MARYLAND, BALTIMORE CORDAY, CAMERON A 3745 §102§103 Final Rejection — Pending Apr 19, 2024
18702968 SYSTEM AND METHOD FOR PREDICTING AND OPTIMIZING DRILLING PARAMETERS Exebenus AS HUYNH, PHUONG §101§102§103 Non-Final OA — Pending Apr 19, 2024
18703099 TADALAFIL ORAL SUSPENSION Farmalíder, S.A. CHAO, ALLEN 1622 §103 Non-Final OA — Pending Apr 19, 2024
18701967 METHODS TO REGULATE GLYCOLYSIS VIA TARGETING EXTRACELLULAR ALPHA-ENOLASE FOR TREATING HUMAN DISEASES Hunilife Biotechnology, Inc. HAUK TEODORO, PRICILA NMN 1645 §102§112 Final Rejection — Pending Apr 17, 2024
18701026 RECOMBINANT SACCHAROMYCES CEREVISIAE STRAINS FOR ENZYMATIC HYDROLYSIS OF BIOPLASTIC POLYMERS Stellenbosch University LOUNTOS, GEORGE THEMISTOCLIS 1652 §103§112 Non-Final OA — Pending Apr 12, 2024
18701156 MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE The Cleveland Clinic Foundation CHESTNUT, BARRY A §103§112 Non-Final OA — Pending Apr 12, 2024
18632426 USE OF BIOMARKERS TO DETERMINE WHETHER A SUBJECT HAS SUSTAINED, MAY HAVE SUSTAINED OR IS SUSPECTED OF SUSTAINING A SUBACUTE ACQUIRED BRAIN INJURY (ABI) Abbott Laboratories ROBINSON, HOPE A 1652 §102§103§112 Non-Final OA — Pending Apr 11, 2024
18699932 BLOOD COLLECTION DEVICE The University of Melbourne HANEY, JONATHAN MICHAEL 3791 §102§103§112 Non-Final OA — Pending Apr 10, 2024
18699698 PHARMACEUTICAL COMPOSITION CONTAINING 27-HYDROXYCHOLESTEROL FOR PREVENTING OR TREATING MYELOID LEUKEMIA Pusan National University Industry-University Cooperation Foundation HOWELL, THEODORE R 1628 §102§112 Final Rejection — Pending Apr 09, 2024
18697110 ATTRITIVE CARBON DIOXIDE CAPTURE AS FRIABLE MAGNESIUM CARBONATE PARTICULATES Negative Emissions Materials, Inc. LACLAIR, LOGAN EDWARD §103 Non-Final OA — Pending Mar 29, 2024
18695845 COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE The Regents of the University of Michigan ANTHOPOLOS, PETER 1617 §103§112DP Non-Final OA — Pending Mar 27, 2024
18695991 HALOPERIDOL FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY Fundación Para La Investigación Del Hospital Clínico De La Comunidad Valenciana IVANOVA, SVETLANA M 1627 §103 Final Rejection — Pending Mar 27, 2024
18694220 UNIVERSAL HAIRPIN PRIMER SYSTEM FOR QUANTIFICATION OF MICRORNA The University of Chicago CHUNDURU, SURYAPRABHA §102 Non-Final OA — Pending Mar 21, 2024
18694281 METABOLITE BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PANCREATIC CYSTS The Regents of the University of Michigan XU, XIAOYUN §101§102§103 Non-Final OA — Pending Mar 21, 2024
18694253 TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING Gen-Probe Incorporated CHUNDURU, SURYAPRABHA 1681 §103 Non-Final OA — Pending Mar 21, 2024
18693381 RAW MATERIAL, FILM PACKAGE, AND CONTAINER Fuji Seal International, Inc. LAN, YAN §102§103 Non-Final OA — Pending Mar 19, 2024
18692704 MOULDED ARTICLE AND METHOD OF MANUFACTURE Invibio Knees Limited HUANG, STEVEN §103 Non-Final OA — Pending Mar 15, 2024
18599465 SYSTEMS AND METHODS FOR TISSUE CUTTING SYSTEM WITH VISION Elephas Biosciences Corporation XU, XIAOYUN §103 Non-Final OA — Pending Mar 08, 2024
18596338 TRIAGE BIOMARKERS AND USE THEREFOR Immunexpress Pty Ltd. SALMON, KATHERINE D 1682 §103 Non-Final OA — Pending Mar 05, 2024
18595339 ENGINEERED DNA POLYMERASE WITH REDUCED ARTIFACT FORMATION Promega Corporation PAK, YONG D 1683 §101§102§103§112DP Non-Final OA — Pending Mar 04, 2024
18594798 DIAGNOSTIC BIOMARKERS FOR LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2H AND USE THEREOF The Catholic University Of Korea Industry Academic Cooperation Foundation WECKER, JENNIFER §101§102§103 Non-Final OA — Pending Mar 04, 2024
18592942 WATERCRAFT WITH LIQUID COOLED DISPLAY Arc Boat Company DECKER, JAMIL ALEXANDER 2835 §103 Non-Final OA — Pending Mar 01, 2024
18687993 TOPICAL DRUG TREATMENT TO PREVENT OR REDUCE CORNEAL SCARRING The Cleveland Clinic Foundation OH, TAYLOR V 1625 §103 Non-Final OA — Pending Feb 29, 2024
18589673 COMPOSITIONS AND METHODS FOR TREATING PAIN IN ANIMALS North Carolina State University HUI, SAN MING R 1627 §112 Final Rejection — Pending Feb 28, 2024
18687122 CARBON-BASED CONDUCTING INKS Advanced Material Development Limited THOMAS, JAISON P §102§103§112 Non-Final OA — Pending Feb 27, 2024
18686950 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS Arizona Board of Regents VALLE, ERNESTO 1623 §103§112DP Non-Final OA — Pending Feb 27, 2024
18686693 METHOD FOR STAINING MITOCHONDRIA Tocris Cookson Limited DEKARSKE, MADELINE MCGUIRE 1634 §103DP Non-Final OA — Pending Feb 26, 2024
18586721 METHODS FOR DETECTING IMMUNOGLOBULIN G, SUBCLASS 4 (IgG4) IN A BIOLOGICAL SAMPLE Abbott Laboratories MONTGOMERY, ANN Y §112 Non-Final OA — Pending Feb 26, 2024
18685958 NON-OPIOID METHODS FOR TREATING PAIN UNIVERSITY OF CONNECTICUT CESARE, JOSEPH DAVID §102§103§112 Non-Final OA — Pending Feb 23, 2024
18583685 CATALASE MIMETIC PEPTIDES Northwestern University SHELTON, SYNPHANE LA'SHAWN 1652 §102§103§112 Final Rejection — Pending Feb 21, 2024
18441809 METHODS FOR SEQUENCING BIOPOLYMERS Arizona Board of Regents WILDER, CYNTHIA B §101 Non-Final OA — Pending Feb 14, 2024
18683429 BURDEN-ADDICTED PRODUCTION STRAINS Enduro Genetics Aps EDWARDS, JESSICA FAYE 1657 §102§103§112DP Non-Final OA — Pending Feb 13, 2024
18435731 NUCLEIC ACID SEQUENCE ANALYSIS Arizona Board of Regents KAPUSHOC, STEPHEN THOMAS 1683 §102§103§112 Non-Final OA — Pending Feb 07, 2024
18425156 WATERCRAFT WITH ADJUSTABLE CENTER OF GRAVITY Arc Boat Company BURGESS, MARC R 3615 §103 Final Rejection 3d overdue Pending Jan 29, 2024
18425731 PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS The University of Chicago HINES, JANA A 1645 §102 Non-Final OA 119d overdue Pending Jan 29, 2024
18579227 COMPOSITIONS AND METHODS FOR TREATING ALPHA-SYNUCLEINOPATHIES The Johns Hopkins University ALDARONDO, DASIA ALI §102§103 Non-Final OA — Pending Jan 12, 2024
18579135 METHODS FOR HAIR GROWTH The Regents of the University of Michigan BORI, IBRAHIM D 1629 §102§103 Final Rejection 20d Pending Jan 12, 2024
18578558 COMPOSITIONS, METHODS, AND SYSTEMS FOR ENHANCED DNA TRANSFORMATION IN BACTERIA North Carolina State University FLINDERS, JEREMY C §102 Non-Final OA — Pending Jan 11, 2024
18410314 COMPOSITIONS FOR DISTINGUISHING BETWEEN DIFFERENT CONDITIONS Immunexpress Pty Ltd. DAUNER, JOSEPH G 1682 §103§112 Non-Final OA — Pending Jan 11, 2024
18577942 COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS Acrigen Biosciences STOCKDALE, JESSICA NICOLE 1663 §102§103§112 Non-Final OA — Pending Jan 09, 2024
18576049 MEANS AND METHODS FOR THE TREATMENT OF CALCIUM CRYSTAL DEPOSITION DISEASES Academisch Ziekenhuis Maastricht BORGEEST, CHRISTINA M §112 Non-Final OA — Pending Jan 02, 2024
18575597 ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE Comell University MARTIN, RACHEL E 1657 §102§103§112 Non-Final OA 28d overdue Pending Dec 29, 2023
18575591 METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE The Regents of the University of Michigan OGUNTADE, ELIZABETH BISOLA §101§102§103§112 Non-Final OA — Pending Dec 29, 2023
18572884 COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES The Regents of the University of Michigan STEVENS, MARK V 1613 §101§102§103§112DP Final Rejection 28d Pending Dec 21, 2023
18392091 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PATHOLOGICAL FIBROBLAST CELLS Duke University MELCHIOR, JAMES RYLAND §101§102§103§112DP Non-Final OA — Pending Dec 21, 2023
18571967 COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN TRANSLATION FROM RECOMBINANT CIRCULAR RNAS The Board Of Trustees Of The Leland Stanford Junior University KONOPKA, CATHERINE ANNE 1636 §112 Non-Final OA — Pending Dec 19, 2023
18544247 GENE THERAPY TREATMENT OF ATRIAL FIBRILLATION Northwestern University LANDSMAN, ROBERT S §103DP Non-Final OA — Pending Dec 18, 2023
18570914 SYSTEMS, METHODS, AND COMPONENTS FOR RNA-GUIDED EFFECTOR RECRUITMENT The Trustees of Columbia University in the City of New York POLIAKOVA-GEORGAN, EKATERINA §101§102§103§112DP Non-Final OA — Pending Dec 15, 2023
18570834 SYSTEMS AND METHODS FOR MONITORING AND TREATING STROKE Arizona Board of Regents WEIDNER, ADAM M 1675 §103 Final Rejection 13d Pending Dec 15, 2023
18541250 BIOEFFECTIVE KRILL OIL COMPOSITIONS Aker BioMarine Human Ingredients AS FAN, LYNN Y 1759 DP Non-Final OA 5d overdue Pending Dec 15, 2023
18569677 AURKA SELECTIVE DEGRADATION INDUCING COMPOUND UPPTHERA MAHLUM, JONATHAN DAVIS 1625 §103§112 Non-Final OA — Pending Dec 13, 2023
18568615 COMPOSITIONS AND METHODS FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS Colorado State University Research Foundation VAJDA, KRISTIN ANN 1622 §102§103 Non-Final OA — Pending Dec 08, 2023
18532395 MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF Catalent Pharma Solutions, LLC LU, CHENG 1642 §103 Non-Final OA — Pending Dec 07, 2023
18567543 HIGH PERFORMANCE AQUEOUS HALIDE PEROVSKITE NANOCRYSTALS Nanyang Technological University BAEK, JONGHWAN NMN 1618 §103§112 Non-Final OA — Pending Dec 06, 2023
18530387 IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS Amgen K-A, Inc. BRISTOL, LYNN ANNE 1643 §112DP Non-Final OA — Pending Dec 06, 2023
18567255 METHOD OF RECOVERING METAL IONS FROM BATTERIES Nanyang Technological University LACLAIR, LOGAN EDWARD 1736 §102§103§112Other Non-Final OA 40d Pending Dec 05, 2023
18528348 GENERATING QUIESCENT HEPATIC STELLATE CELLS AND THEIR USE IN LIVER MODELS The Cleveland Clinic Foundation LARA, CAROLINE MONSERRAT 1633 §102§103§112DP Non-Final OA — Pending Dec 04, 2023
18565023 COMPOSITIONS AND METHODS TO TRANSFECT, TEST, AND TREAT SKIN CELLS The Regents of the University of Michigan SULLIVAN, DENNIS JOHN §103 Non-Final OA — Pending Nov 28, 2023
18521870 UNIVERSAL SENSING SYSTEM Abbott Laboratories MACFARLANE, STACEY NEE 1675 §101§102§112 Non-Final OA — Pending Nov 28, 2023
18519188 ENGINEERED INTERLEUKIN-10 AND FUSION PROTEINS THEREOF Elixiron Immunotherapeutics (Hong Kong) Limited PRIEST, JESSICA MARIE 1642 §101§102§103§112DP Non-Final OA — Pending Nov 27, 2023
18563568 THIADIAZOLIDINONES FOR THEIR USE IN THE TREATMENT OF LIMB-GIRDLE MUSCULAR DYSTROPHY Administración General De La Comunidad Autónoma De Euskadi SAMSELL, RILLA MARIE 1624 §103§112 Final Rejection 5d overdue Pending Nov 22, 2023
18563554 1,2-DIHYDROQUINOLINE-2-ONES FOR THEIR USE IN THE TREATMENT OF LIMB-GIRDLE MUSCULAR DYSTROPHY Administración General De La Comunidad Autónoma De Euskadi HSU, GRACE CHING 1627 §103§112 Non-Final OA 17d overdue Pending Nov 22, 2023
18563175 CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING Cornell University NGUYEN, QUANG 1631 §102§103§112DP Non-Final OA — Pending Nov 21, 2023
18563026 MUTANT RNASE E FOR ENHANCING RECOMBINANT PROTEIN EXPRESSION Danmarks Tekniske Universitet MULDER, SCOTT EVAN 1656 §103§112 Non-Final OA — Pending Nov 21, 2023
18516026 APPARATUS AND DEVICES FOR PROCESSING FLUID SAMPLES Abbott Point Of Care Inc. GORDON, BRIAN R 1798 §112 Final Rejection — Pending Nov 21, 2023
18509717 BIOMARKERS FOR USE IN DETERMINING TRAUMATIC BRAIN INJURY (TBI) Abbott Laboratories GIERE, REBECCA M §101§103§112DP Non-Final OA — Pending Nov 15, 2023
18387625 STABLE INTERFACE SYSTEMS AND METHODS Flambeau Diagnostics, LLC SHI, TINGCHEN 1796 §102§103§112 Non-Final OA — Pending Nov 07, 2023
18559244 METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC PROSTATITIS AND/OR CHRONIC PELVIC PAIN SYNDROME Northwestern University EIX, EMILY FAY 1653 §101§102 Non-Final OA — Pending Nov 06, 2023
18558919 COMPOSITIONS AND METHODS RELATED TO THE TREATMENT OF OCULAR DISEASES IN EQUINES The University of North Carolina at Chapel Hill NGUYEN, QUANG 1631 §102§103§112 Final Rejection 46d Pending Nov 03, 2023
18289431 COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION Abbott Laboratories MILLER, DALE R 1693 §103 Non-Final OA — Pending Nov 03, 2023
18289354 SAMPLE COLLECTION DEVICES AND METHODS OF USING THE SAME Flambeau Diagnostics, LLC GZYBOWSKI, MICHAEL STANLEY 1798 §103 Final Rejection — Pending Nov 02, 2023
18000634 ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS R&D Systems, Inc. SWIFT, CANDICE LEE 1657 §112 Final Rejection 43d Pending Nov 01, 2023
18288937 13C METHACETIN GRANULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Richen-Bases Bio & Sci Co., Ltd. ROGERS, JAMES WILLIAM 1618 §103 Non-Final OA — Pending Oct 30, 2023
18558061 ANALYTE DETECTION CARTRIDGE AND METHODS OF USE THEREOF Nuclein, LLC CROW, ROBERT THOMAS 1683 §102§103§112 Non-Final OA — Pending Oct 30, 2023
18557339 USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER UNIVERSIDAD DE NAVARRA CHEN, STACY BROWN 1672 §112 Non-Final OA — Pending Oct 26, 2023
18495141 HYDROPORPHYRIN-DOPED NEAR-INFRARED-EMITTING POLYMER DOTS FOR CELLULAR FLUORESCENCE IMAGING UNIVERSITY OF MARYLAND, BALTIMORE MOSHER, ERIC PARKER 1612 §103 Final Rejection — Pending Oct 26, 2023
18556564 PROTEASE INHIBITORS AND METHODS OF USE The Cleveland Clinic Foundation BARSKY, JARED 1628 §102§112 Final Rejection 13d Pending Oct 20, 2023
18556311 3D-PRINTING OF STRONG LIVING SCAFFOLDS Northwestern University KWON, JOHN SEUNGJAI 3783 §103 Non-Final OA — Pending Oct 19, 2023
18287427 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS THROUGH INHIBITION OF CD44 AND FERM PROTEIN INTERACTION Arizona Board of Regents KIM, SEONG JONG 1621 §102§112 Non-Final OA 26d Pending Oct 18, 2023
18486892 COELENTERAZINE ANALOGUES Promega Corporation BRADY, KRISTEN WEEKS 1692 §103 Final Rejection — Pending Oct 13, 2023
18485930 RESCUE STRATEGIES FOR BEST1 LOSS- AND GAIN-OF-FUNCTION MUTATIONS UNIVERSITY OF ROCHESTER ALLEN, SARAH ELIZABETH 1637 §103§112 Non-Final OA — Pending Oct 12, 2023
18484137 ENGINEERED VASCULAR TISSUE MODELS The Johns Hopkins University SCHUBERG, LAURA J 1631 §103DP Non-Final OA 43d Pending Oct 10, 2023
18285971 COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS Arizona Board of Regents SHOMER, ISAAC 1612 §103§112 Final Rejection — Pending Oct 06, 2023
18482752 GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-CELL MALIGNANCIES Crispr Therapeutics AG FAUST, AMBER KATHLEEN 1643 §103§112DP Non-Final OA — Pending Oct 06, 2023
18478684 TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY The Cleveland Clinic Foundation MAHLUM, JONATHAN DAVIS 1625 §103§112DP Non-Final OA — Pending Sep 29, 2023
18474826 BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY Abbott Laboratories COUNTS, GARY W 1678 §101§103 Final Rejection 5d Pending Sep 26, 2023
18284035 CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF The Regents of the University of Michigan MEJIAS, SAMANTHA LEE 1618 §103§112 Non-Final OA — Pending Sep 25, 2023
18551809 COMPOSITE DRUG PARTICLES AND USES THEREOF The Regents of the University of Michigan DAVIS, BRIAN J 1614 §102 Non-Final OA — Pending Sep 21, 2023
18551562 RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE North Carolina State University GU, QINHUA 1633 §103 Non-Final OA 46d overdue Pending Sep 20, 2023
18551547 COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION Duke University CHEN, STACY BROWN 1672 §102§103§112 Non-Final OA — Pending Sep 20, 2023
18368905 MICROSCOPE SURVEILLANCE SYSTEM The Regents of the University of Michigan WONG, ALLEN C 2488 §103Other Non-Final OA 15d Pending Sep 15, 2023
18467510 RNA PRINTING AND SEQUENCING DEVICES, METHODS, AND SYSTEMS The Trustees of Columbia University in the City of New York WILDER, CYNTHIA B 1681 §103 Non-Final OA — Pending Sep 14, 2023
18548793 TREATMENT Queen Mary University London PETERS, ALEC JON 1641 §102§103§112 Non-Final OA — Pending Sep 01, 2023
18241411 COMPOSITIONS AND METHODS FOR DETECTING GYNECOLOGICAL CANCER Mayo Foundation for Medical Education and Research GOLDBERG, JEANINE ANNE 1682 §103 Non-Final OA — Pending Sep 01, 2023
18457679 RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER Promega Corporation MISHRA, DEEPA 1657 §103§112 Non-Final OA — Pending Aug 29, 2023
18279183 ALUMINUM NITRIDE GRANULAR POWDER AND RESIN COMPOSITION Tokuyama Corporation KOLB, KATARZYNA I 1767 §103 Final Rejection — Pending Aug 28, 2023
18278676 FLUORESCENT BIOSENSORS AND METHODS OF USE FOR DETECTING CELL SIGNALING EVENTS The Regents of the University of Michigan HOWARD, ZACHARY C 1674 §112 Final Rejection — Pending Aug 24, 2023
18278196 COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH MULTIPLE ORGAN FAILURE Arizona Board of Regents TATGE, LEXUS MARC 1637 §101§102§103§112Other Non-Final OA 40d Pending Aug 22, 2023
18236022 BIOMARKERS OF RISK FOR INFECTION University Of Chicago GREENE, CAROLYN LEE 1681 §112 Non-Final OA 34d Pending Aug 21, 2023
18546378 SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY North Carolina State University SU-TOBON, QIWEN NMN 1636 §102§103§112DP Non-Final OA — Pending Aug 14, 2023
18366237 PLATELET TARGETED TREATMENT Platelet Targeted Therapeutics, LLC QIAN, CELINE X 1637 §112 Final Rejection 13d Pending Aug 07, 2023
18263929 TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES The Cleveland Clinic Foundation BUNNER, BRIDGET E 1647 §102§112 Non-Final OA — Pending Aug 02, 2023
18273942 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF The Regents of the University of Michigan LEE, CHIHYI NMN 1628 §102§103§112 Final Rejection 27d Pending Jul 24, 2023
18353647 COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA Exact Sciences Corporation HANEY, AMANDA MARIE 1682 Other Non-Final OA 33d Pending Jul 17, 2023
18350161 COMPOSITIONS AND METHODS TO IMPROVE IPSC-EC FUNCTION Northwestem University CANDELARIA, JULIANA IRENE 1634 §102§103§112 Final Rejection — Pending Jul 11, 2023
18344952 METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE Abbott Laboratories ZOU, NIANXIANG 1671 §102§103§112 Final Rejection 70d Pending Jun 30, 2023
18345614 ANGLED TRANSCRANIAL MAGNETIC STIMULATION DEVICE UNIVERSITY OF MARYLAND, BALTIMORE LANDEEN, BROGAN RANE 3791 §103§112 Final Rejection — Pending Jun 30, 2023
18343417 CROSSLINKING COMPOUNDS AND CROSSLINKED ACRYLIC POLYMERIC MATERIALS Massachusetts Institute Of Technology ROSWELL, JESSICA MARIE 1767 §102 Non-Final OA — Pending Jun 28, 2023
18246943 CELL CULTURE VESSEL, OBSERVATION DEVICE, MICROSCOPE, CULTURE METHOD, AND OBSERVATION METHOD Riken KRCHA, MATTHEW D 1796 §103 Final Rejection — Pending Jun 26, 2023
18340582 GENETIC ELEMENTS DRIVING CIRCULAR RNA TRANSLATION AND METHODS OF USE The Board Of Trustees Of The Leland Stanford Junior University HUDSON, AMY ROSE 1636 DP Non-Final OA — Pending Jun 23, 2023
18269021 COMPOSITIONS AND METHODS FOR CONTROLLING PSYLLIDS Arizona Board of Regents ORDAZ, CHRISTIAN JOSE 1663 §102§103§112Other Non-Final OA — Pending Jun 22, 2023
18258758 AMYLOID-SPECIFIC ANTIBODIES AND USES THEREOF The Regents of the University of Michigan BERHANE, SELAM 1675 §112 Final Rejection — Pending Jun 21, 2023
18257167 CB2 RECEPTOR AGONISTS The Board Of Trustees Of The Leland Stanford Junior University BAUER, NICOLA MARIA 1621 §102§103 Non-Final OA — Pending Jun 13, 2023
18257261 PI3K INHIBITORS FOR PROTECTION AGAINST GLUCOCORTICOID-INDUCED ATROPHY Northwestern University MAHLUM, JONATHAN DAVIS 1625 §102§103§112 Non-Final OA — Pending Jun 13, 2023
18334135 TRANS-INTERFACIAL MAGNETIC SEPARATION Northwestern University MARCSISIN, ELLEN JEAN 1677 §102§103 Non-Final OA 14d Pending Jun 13, 2023
18257168 KNEE IMPLANT Invibio Knees Limited MATHEW, SEEMA 3774 §102§103 Final Rejection 28d overdue Pending Jun 13, 2023
18266889 Reversible Electrochemical Mirror (REM) Nanyang Technological University WITTENBERG, STEFANIE S 1795 §103 Non-Final OA — Pending Jun 13, 2023
18256241 BYSTANDER PROTEIN VACCINES Iogenetics, LLC CUNNINGCHEN, KATHLEEN MARY 1646 §103§112 Final Rejection — Pending Jun 07, 2023
18256242 ADMINISTRATION OF ANTI-TUMOR VACCINES Asthra, LLC YU, MISOOK 1641 §103§112DPOther Non-Final OA — Pending Jun 07, 2023
18265335 COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION Arizona Board of Regents DAHLIN, HEATHER RAQUEL 1629 §102§112 Final Rejection 23d overdue Pending Jun 05, 2023
18039641 BIOMARKER AND TREATMENT FOR VASCULAR COGNITIVE IMPAIRMENT AND RELATED CONDITIONS National Institutes Of Health FRITCHMAN, REBECCA M 1758 §103 Non-Final OA — Pending May 31, 2023
18038585 VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF Glen Clova Scientific Limited FOLEY, SHANON A 1671 §112 Final Rejection — Pending May 24, 2023
18323031 DETECTING PROSTATE CANCER Exact Sciences Corporation SALMON, KATHERINE D 1682 §103 Non-Final OA — Pending May 24, 2023
18200932 IN VIVO DETECTION OF SURGICAL MATERIALS Northwestern University RAYMOND, LINNAE ELIZABETH 3781 §103§112 Final Rejection 23d Pending May 23, 2023
18037966 POLYCRYSTAL SILICON ROD, POLYCRYSTAL SILICON ROD PRODUCTION METHOD, AND POLYCRYSTAL SILICON THERMAL PROCESSING METHOD Tokuyama Corporation SONG, MATTHEW J 1714 §103§112 Final Rejection 60d Pending May 19, 2023
18037144 ADHESIVE COMPOSITION Moresco Corporation FISCHER, JUSTIN R 1749 §103 Non-Final OA — Pending May 16, 2023
18252928 ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA The Cleveland Clinic Foundation CHATTIN, AMY MARIE 1643 §103§112 Final Rejection — Pending May 15, 2023
18196229 IMAGING PHANTOM The Regents of the University of Michigan BAEK, JONGHWAN NMN 1618 §102§103DP Final Rejection 5d Pending May 11, 2023
18035894 ANTIBODY-BASED CONJUGATE FOR ENHANCING THERAPEUTIC EFFECT OF TARGETED THERAPEUTIC AGENT The Catholic University Of Korea Industry-Academic Cooperation Foundation DAHLE, CHUN WU 1641 §102§103§112 Non-Final OA — Pending May 08, 2023
18313856 COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS The Regents of the University of Michigan DABKOWSKI, ERINNE R 1654 §103 Final Rejection 37d overdue Pending May 08, 2023
18312117 SPLIT MODIFIED DEHALOGENASE VARIANTS Promega Corporation BOWERS, ERIN M 1653 §103 Non-Final OA — Pending May 04, 2023
18035134 COMPOSITIONS AND METHODS FOR SCREENING PESTICIDES Arizona Board of Regents DAVIS, RUTH A 1699 §101§102§112Other Final Rejection — Pending May 03, 2023
18034407 SITE-SELECTIVE MODIFICATION OF PROTEINS Rigshospitalet SABILA, MERCY HELLEN 1654 §103 Final Rejection 22d overdue Pending Apr 28, 2023
18034455 PLANT-DERIVED AEROGELS, HYDROGELS, AND FOAMS, AND METHODS AND USES THEREOF Spiderwort Inc. BABSON, NICOLE PLOURDE 1619 §102§103§112Other Final Rejection — Pending Apr 28, 2023
18034016 DEVICES, SYSTEMS, AND METHODS FOR TREATING KIDNEY STONES The Regents of the University of Michigan ABBASI, ABDUL HADI 3795 §103§112 Non-Final OA 12d Pending Apr 26, 2023
18138313 COMPOSITIONS AND METHODS FOR OBTAINING FUNCTIONAL BASAL-LIKE CELLS The Regents of the University of Michigan FOX, ALLISON M 1633 §102DP Non-Final OA — Pending Apr 24, 2023
18249597 A SCREENING PLATFORM FOR ADAR-RECRUITING GUIDE RNAS The Board Of Trustees Of The Leland Stanford Junior University LU, FRANK WEI MIN 1683 §112 Final Rejection 14d Pending Apr 19, 2023
18135893 CONSTRUCTION METHOD AND APPLICATION OF MICROTUBE-BASED IONIC LIQUID COLLOID/WATER INTERFACE East China Normal University CUTLIFF, YATE KAI RENE 1692 §112 Non-Final OA 142d overdue Pending Apr 18, 2023
18032149 COMPOSITIONS AND METHODS FOR DRUG DELIVERY North Carolina State University CREWS, JARET JAMES 1691 §103§112 Non-Final OA — Pending Apr 14, 2023
18298540 RAPID AND LOW-COST SAMPLING FOR DETECTION OF AIRBORNE SARS-COV-2 IN DEHUMIDIFIER CONDENSATE UNIVERSITY OF MARYLAND, BALTIMORE GILL, RACHEL B 1671 §103§112 Non-Final OA — Pending Apr 11, 2023
18132495 SYSTEMS AND METHODS OF INDIVIDUAL ANIMAL IDENTIFICATION TrueTrace Biometrics, Inc. AZIMA, SHAGHAYEGH 2671 §103 Non-Final OA 20d Pending Apr 10, 2023
18030223 ENHANCEMENT OF ANTI-TUMOR PHAGOCYTOSIS The Board Of Trustees Of The Leland Stanford Junior University AEDER, SEAN E 1642 §112 Final Rejection 21d Pending Apr 04, 2023
18029391 3D STRUCTURES FOR CELL GROWTH Academisch Ziekenhuis Maastricht MARTIN, PAUL C 1653 §103 Non-Final OA 8d overdue Pending Mar 30, 2023
18191556 COMPOSITIONS COMPRISING COMBINATIONS OF COLLAGEN OR ELASTIN POLYPEPTIDES WITH ACTIVE INGREDIENTS AND METHODS OF USING SAME Geltor, Inc. SABILA, MERCY HELLEN 1654 §103§112DP Final Rejection 12d Pending Mar 28, 2023
18028256 SILICONE-FREE ANTIPERSPIRANT AND DEODORANT COMPOSITIONS Kdc/One Development Corporation, Inc. MEYERS, ELIZABETH ANNE 1617 §103 Final Rejection 22d overdue Pending Mar 24, 2023
17920698 INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF The Regents of the University of Michigan BRADLEY, CHRISTINA 1654 §101§102§103§112Other Non-Final OA 162d overdue Pending Mar 16, 2023
18245660 METHODS AND COMPOSITIONS FOR REMOVAL OF RNA Advanced Cell Diagnostics, Inc. SALMON, KATHERINE D 1682 §103§112 Non-Final OA 5d overdue Pending Mar 16, 2023
18176918 NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF Promega Corporation RILEY, JEZIA 1681 §102§112DP Non-Final OA — Pending Mar 01, 2023
18176021 CIRCULAR RNAS AND THEIR USE IN IMMUNOMODULATION Emory University LEONARD, ARTHUR S 1631 §103 Final Rejection — Pending Feb 28, 2023
18113981 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS The Trustees of Columbia University in the City of New York LEE, WILLIAM Y 1623 §102§112DP Non-Final OA — Pending Feb 24, 2023
18022840 GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS Covirix Medical Pty Ltd. TOWNSLEY, SARA ELIZABETH 1629 §103 Final Rejection — Pending Feb 23, 2023
18173358 COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH Duke University SCHWECHTER, BRANDON ROSS 1674 §102§103 Non-Final OA — Pending Feb 23, 2023
18170396 EPITOPE MIMICS Iogenetics, LLC KALLAL, ROBERT JAMES 1685 §101§112 Non-Final OA 16d Pending Feb 16, 2023
18169293 AMHR2-ED CANCER VACCINE FORMULATIONS The Cleveland Clinic Foundation DUFFY, BRADLEY 1643 §103DP Final Rejection 23d overdue Pending Feb 15, 2023
18169326 OXAZINE DYES AND THEIR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS Promega Corporation WARD, PAUL V 1622 §103§112 Non-Final OA — Pending Feb 15, 2023
18020908 N-ACYL AMINO ACID PRODUCTS AND USES The Regents of the University of Michigan HELLMAN, KRISTINA M 1654 §103§112DP Non-Final OA 35d Pending Feb 10, 2023
18020320 COMPOSITION COMPRISING OXIRACETAM FOR PREVENTING OR TREATING MUSCULAR DISEASE Ksb Tugen Inc. LEE, WILLIAM Y 1623 §102§103§112 Non-Final OA — Pending Feb 08, 2023
18041059 COMPANION DIAGNOSTIC FOR RTK INHIBITORS The Regents of the University of Michigan DENT, ALANA HARRIS 1643 §102§103DP Non-Final OA — Pending Feb 08, 2023
18040508 (1R,3S)-3-((5-CYANO-4-PHENYLTHIAZOL-2-YL)CARBAMOYL)CYCLOPENTANE-1-CARBOXYLIC ACID AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF AIRWAY DISEASES Palobiofarma, S.L. LEE, ANDREW P 1691 §103 Non-Final OA 84d overdue Pending Feb 03, 2023
18163773 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS The Regents of the University of Michigan DABKOWSKI, ERINNE R 1654 DP Non-Final OA — Pending Feb 02, 2023
18161253 EXTENDING FRUIT JUICE SHELF LIFE, CONSTITUENT MANIPULATION, AND QUALITY PRESERVATION PROCESS Smartflow Technologies, Inc. TAYLOR, AUSTIN PARKER 1792 §103§112 Non-Final OA 34d Pending Jan 30, 2023
18017891 ELECTRODE INTEGRATED MICROSIEVE ASSEMBLY Technische Universiteit Eindhoven KASS, BENJAMIN JOSEPH 1798 §102 Final Rejection 27d Pending Jan 25, 2023
18017107 CLOSED MANUFACTURING PROCESSES FOR LARGE SCALE MANUFACTURING OF PLURIPOTENT STEM CELL DERIVED CELLS Ncardia B.V. RAHMAN, MASUDUR 1633 §103§112 Non-Final OA — Pending Jan 20, 2023
18098538 THERAPEUTIC DELIVERY DEVICE UNIVERSITY OF UTAH RESEARCH FOUNDATION VU, QUYNH-NHU HOANG 3783 §102§103 Non-Final OA 33d Pending Jan 18, 2023
18005519 PHOTOREDOX PROTEIN MODIFICATION The Rosalind Franklin Institute JARRELL, NOBLE E 1699 §112 Non-Final OA 75d Pending Jan 13, 2023
18015775 SMALL MOLECULE INHIBITORS OF TDP-43 ACTIVITY AND USES THEREOF Arizona Board of Regents PECKHAM, RICHARD GRANT 1627 §102§103§112DP Non-Final OA — Pending Jan 12, 2023
18004082 BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF UNIVERSIDAD DE GRANADA HINES, JANA A 1645 §101§102§103 Final Rejection 36d overdue Pending Jan 03, 2023
18003807 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION The Cleveland Clinic Foundation LEE, CHIHYI NMN 1628 §102§103§112Other Non-Final OA 6d Pending Dec 29, 2022
18147094 USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN Abbott Laboratories FRITCHMAN, REBECCA M 1758 §102§112 Non-Final OA 27d Pending Dec 28, 2022
18147360 METHODS OF DIAGNOSING BRAIN INJURY Abbott Laboratories CHERNYSHEV, OLGA N 1675 DP Final Rejection 30d Pending Dec 28, 2022
18147420 METHODS AND SYSTEMS OF DIAGNOSING BRAIN INJURY Abbott Laboratories FONTAINHAS, AURORA M 1675 §101§102DP Final Rejection — Pending Dec 28, 2022
18003431 HISTONE-ACETYLATION-MODULATING AGENTS FOR THE TREATMENT AND PREVENTION OF ORGAN INJURY The Regents of the University of Michigan WELLS, LAUREN QUINLAN 1622 §103§112 Final Rejection — Pending Dec 27, 2022
18069546 COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS Northern Sydney Local Health District WANG, CHANG YU 1675 §103§112 Non-Final OA 1d overdue Pending Dec 21, 2022
18080868 ENDOSCOPIC IMAGING AND PATTERNED STIMULATION AT CELLULAR RESOLUTION Duke University FERNANDEZ, KATHERINE L 3798 §103 Final Rejection 16d Pending Dec 14, 2022
18009096 METHODS FOR PRODUCING A (THREE DIMENSIONAL) NEURAL TISSUE Technische Universiteit Eindhoven MI, QIUWEN 1655 §103 Non-Final OA 43d Pending Dec 08, 2022
18008766 SUBSTRATE FOR IMMOBILIZING SUBSTANCE, AND USE THEREOF R-Nanobio Co. Ltd. GROSS, CHRISTOPHER M 1684 §102§112 Final Rejection — Pending Dec 07, 2022
17928674 COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS The Trustees of Columbia University in the City of New York WESTON, ALYSSA G 1633 §102§103 Final Rejection 16d overdue Pending Nov 30, 2022
18060215 COMPOSITIONS AND METHODS FOR PURIFYING ALPHA-1 ANTITRYPSIN USING PEPTIDE LIGANDS North Carolina State University SZPERKA, MICHAEL EDWARD 1641 §102§112 Final Rejection 3d overdue Pending Nov 30, 2022
17928452 USE OF MICROVESICLE SIGNATURE FOR THE DIAGNOSIS AND TREATMENT OF KIDNEY TRANSPLANT REJECTION The Brigham And Women'S Hospital, Inc. YU, TIAN NMN 1681 §101§103 Non-Final OA — Pending Nov 29, 2022
17928075 SMALL MOLECULE INHIBITORS OF GRK5 AND GRK5 SUBFAMILY MEMBERS AND USES THEREOF Purdue Research Foundation HEASLEY, MEGHAN CHRISTINE 1626 §102 Non-Final OA 46d overdue Pending Nov 28, 2022
17999437 AN APPARATUS COMPRISING MICROFLUIDIC PROTEIN-BASED SENSORS AND METHODS OF USING SAME UNIVERSITY OF MARYLAND, BALTIMORE IANNUZO, NATALIE NMN 1653 §103 Non-Final OA — Pending Nov 21, 2022
17998761 CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND DETECTING OCULAR TUMORS The Regents of the University of Michigan CABRAL, ROBERT S 1614 §103 Final Rejection — Pending Nov 14, 2022
17924612 COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL STORAGE DISORDERS The Board Of Trustees Of The Leland Stanford Junior University LI, RUIXIANG 1674 §102§112Other Non-Final OA 53d Pending Nov 10, 2022
17923671 FLUID INJECTION DEVICE FOR INJECTING A FLUID BEHIND THE TYMPANIC MEMBRANE Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis DAVIS, JASON GREGORY 3745 §102§103§112 Non-Final OA 167d overdue Pending Nov 07, 2022
17980961 METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS The Regents of the University of California KOMATSU, LI N 1658 §103DP Final Rejection — Pending Nov 04, 2022
18052449 PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY The University of Chicago PECKHAM, RICHARD GRANT 1627 §112 Non-Final OA — Pending Nov 03, 2022
17921711 DETECTING MELANOMA Exact Sciences Corporation KENNEDY, SARAH JANE 1682 §101§103 Non-Final OA — Pending Oct 27, 2022
18050071 HIGHLY SPECIFIC CIRCULAR PROXIMITY LIGATION ASSAY The Board Of Trustees Of The Leland Stanford Junior University GRAY, JESSICA 1682 §103§112DPOther Final Rejection 78d Pending Oct 27, 2022
17920599 STEM CELL DERIVED SINGLE-ROSETTE BRAIN ORGANOIDS AND RELATED USES THEROF The Regents of the University of Michigan EBBINGHAUS, BRIANA NOEL 1632 §103 Non-Final OA — Pending Oct 21, 2022
17920061 PERMEABILIZED MICROBIAL CELL CATALYSTS Danmarks Tekniske Universitet RODGERS, ARIEL M 1792 §103 Non-Final OA — Pending Oct 20, 2022
17996565 METHODS AND SYSTEMS FOR OBTAINING HINGE AXIS POSITION AND CONDYLE GUIDE INCLINATION FROM A PATIENT The Regents of the University of Michigan APONTE, MIRAYDA ARLENE 3772 §101§102 Final Rejection — Pending Oct 19, 2022
18045845 METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE Abbott Laboratories EVANS, CHRISTOPHER RYAN 1677 §101§102§103§112Other Non-Final OA — Pending Oct 12, 2022
18045534 METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION Amgen K-A, Inc. JIANG, DONG 1674 §103§112Other Non-Final OA 36d overdue Pending Oct 11, 2022
17917425 Keratin Filament Networks Nanyang Technological University TSAY, MARSHA M 1656 §103 Non-Final OA — Pending Oct 06, 2022
17995225 TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS The University of Chicago NICKOL, GARY B 1643 §102 Non-Final OA 146d overdue Pending Sep 30, 2022
17907315 BIOMARKERS FOR PREDICTING A PATIENT'S RESPONSE TO BCG THERAPY, METHODS AND USES BASED THEREON Centro De Investigaciones Energéticas Medioambientales Y Tecnológicas, O.A.M.P. (Ciemat) SALMON, KATHERINE D 1682 §101§102§112 Non-Final OA — Pending Sep 26, 2022
17934810 METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß CORONAVIRUS ANTIBODY IN A SAMPLE Abbott Laboratories WANG, RUIXUE 1672 §103§112 Final Rejection — Pending Sep 23, 2022
17912426 METHOD FOR PRODUCING SURFACE-TREATED SILICA POWDER, RESIN COMPOSITION, AND SLURRY Tokuyama Corporation CASE, SARAH CATHERINE 1731 §103 Non-Final OA 16d Pending Sep 16, 2022
17906471 T-CELL BISPECIFIC BINDING PROTEINS Crispr Therapeutics AG OGUNBIYI, OLUWATOSIN A 1645 §103§112 Non-Final OA 126d overdue Pending Sep 15, 2022
17929809 METHODS AND SYSTEMS FOR PROCESSING TIME-RESOLVED SIGNAL INTENSITY DATA The Regents of the University of Michigan CROW, ROBERT THOMAS 1683 §101§103DP Final Rejection 51d overdue Pending Sep 06, 2022
17909553 MODULATING ANTI-TUMOR IMMUNITY Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis SHUPE, ELIZABETH A 1643 §103 Final Rejection — Pending Sep 06, 2022
17929574 COMPOSITIONS AND METHODS FOR ANALYTE DETECTION Colorado State University Research Foundation BURKHART, MICHAEL D 1638 §102§112 Non-Final OA 36d overdue Pending Sep 02, 2022
17905457 RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE The Board Of Trustees Of The Leland Stanford Junior University ALLEN, SARAH ELIZABETH 1637 §102§103§112DP Final Rejection — Pending Sep 01, 2022
17868358 METHODS OF PREPARING COMPOSITIONS CONTAINING THYMOQUINONE Jina Pharmaceuticals, Inc. HUANG, GIGI GEORGIANA 1613 §103§112 Final Rejection 31d overdue Pending Jul 19, 2022
17868422 SYSTEMS AND METHODS FOR MONITORING PLATELET ACTIVATION The Regents of the University of Michigan SZPERKA, MICHAEL EDWARD 1641 §103Other Final Rejection 26d Pending Jul 19, 2022
17811677 DETECTING GASTROINTESTINAL NEOPLASMS Mayo Foundation for Medical Education and Research DAUNER, JOSEPH G 1682 §103 Final Rejection 19d Pending Jul 11, 2022
17758415 TRANSPOSITION-BASED DIAGNOSTICS METHODS AND DEVICES The Trustees of Columbia University in the City of New York WOOLWINE, SAMUEL C 1681 §102 Non-Final OA 10d overdue Pending Jul 06, 2022
17778306 POLYPEPTIDE INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY AND USES THEREOF The Regents of the University of Michigan STEELE, AMBER D 1658 §103§112Other Non-Final OA 31d overdue Pending May 19, 2022
17775996 ASC SPECKS IN CANCER IMMUNOTHERAPY BOGAZICI UNIVERSITESI PATTERSON, SARAH COOPER 1675 §112 Final Rejection — Pending May 11, 2022
17776131 SYSTEMS AND METHODS FOR RAPID, SENSITIVE MULTIPLEX IMMUNOASSAYS The Regents of the University of Michigan GAO, ASHLEY HARTMAN 1678 §103 Final Rejection — Pending May 11, 2022
17741305 METHYLATED CONTROL DNA Exact Sciences Corporation GOLDBERG, JEANINE ANNE 1682 §101DP Non-Final OA — Pending May 10, 2022
17775812 ENGINEERED IMMUNE KILLER CELL, PREPARATION METHOD THEREFOR AND USE THEREOF Zhaotai Immugene Biomedicine (Hong Kong) Limited DIBRINO, MARIANNE 1641 §103§112Other Final Rejection — Pending May 10, 2022
17775187 MACHINE LEARNING TOOLS AND A PROCESS TO DISCOVER NEW NATURAL PRODUCTS BY LINKING GENOMES AND METABOLOMES IN FUNGI Northwestern University SANFORD, DIANA PATRICIA 1687 §101§103§112 Final Rejection — Pending May 06, 2022
17774875 BIOMATERIALS FOR BONE TISSUE ENGINEERING UNIVERSITY OF OTTAWA HOERNER, PAUL ELLSWORTH 1611 §103 Non-Final OA 72d overdue Pending May 06, 2022
17773895 METHOD FOR ISOLATING NUCLEIC ACIDS Nasasbiotech, S.L. HORLICK, KENNETH R 1681 §112 Non-Final OA 14d Pending May 03, 2022
17727128 DETECTING ESOPHAGEAL DISORDERS Exact Sciences Corporation GOLDBERG, JEANINE ANNE 1682 §103DP Non-Final OA 104d overdue Pending Apr 22, 2022
17768274 COMPOUNDS FOR IMMUNOMODULATION Fundació Institut D'Investigació Biomèdica De Bellvitge (Idibell) MIANO, JOSEPH PAUL 1631 §102§103§112Other Non-Final OA 146d overdue Pending Apr 12, 2022
17764850 IgE Antibody with Fcgamma Receptor binding Epsilogen Ltd. SANG, HONG 1646 §103§112 Non-Final OA 100d overdue Pending Mar 29, 2022
17762980 COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES The Regents of the University of Michigan PATTERSON, SARAH COOPER 1675 §103§112Other Non-Final OA — Pending Mar 23, 2022
17761369 ELECTROENCEPHALOGRAPHY (EEG) ELECTRODE ARRAYS AND RELATED METHODS OF USE BLACKROCK MICROSYSTEMS, LLC MOSSBROOK, WILLIAM ERIC 3794 §103§112 Non-Final OA 34d Pending Mar 17, 2022
17640585 DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS The Regents of the University of Michigan WILSON, MICHAEL C 1638 §103 Final Rejection 33d Pending Mar 04, 2022
17639237 ENGINEERED HUMAN IMMUNE CELLS, PREPARATION METHOD AND APPLICATION THEREOF Zhaotai Immugene Biomedicine (Hong Kong) Limited LEE, YIE CHIA 1642 §103 Final Rejection 27d Pending Feb 28, 2022
17675589 BIOMARKER COMPOSITION, DIAGNOSTIC KIT, AND METHOD FOR PROVIDING INFORMATION Korea University Research And Business Foundation SWITZER, JULIET CAROLINE 1682 §101§102§112 Final Rejection 34d Pending Feb 18, 2022
17674212 SYSTEMS AND METHODS FOR NERVE FIBER CONDUCTION BLOCK Duke University LEE, DAVINA EN-YIN 3794 §103 Final Rejection — Pending Feb 17, 2022
17667683 COLLABORATIVE AUTOMATED DRIVING SYSTEM Cavh LLC SHARMA, SHIVAM 3665 §103 Final Rejection — Pending Feb 09, 2022
17587963 DETECTING THE PRESENCE OR ABSENCE OF MULTIPLE TYPES OF CANCER Exact Sciences Corporation SALMON, KATHERINE D 1682 §103 Non-Final OA — Pending Jan 28, 2022
17630568 ELECTRONIC HAIL PAD Understory, Inc. ISLAM, MOHAMMAD K 2857 §101§102§103 Non-Final OA 89d overdue Pending Jan 27, 2022
17629934 SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS Lifescience AS CHO, DAVID H 1693 §103§112DP Final Rejection — Pending Jan 25, 2022
17629607 BIOCOMPATIBLE HYDROGEL COMPRISING HYALURONIC ACID AND POLYETHYLENE GLYCOL Kyungpook National University Industry-Academic Cooperation Foundation MATTISON, LORI K 1619 §103DP Non-Final OA 96d overdue Pending Jan 24, 2022
17628418 COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS The Regents of the University of Michigan HUYNH, PHUONG N 1641 §103§112 Final Rejection — Pending Jan 19, 2022
17626042 THERAPEUTIC AGENT FOR DISEASE CAUSED BY DOMINANT MUTANT GENE Riken MOLOYE, TITILAYO 1632 §112 Non-Final OA — Pending Jan 10, 2022
17621303 IN SITU RECRUITMENT, REPROGRAMMING, AND RELEASE OF CAR-T CELLS The University of North Carolina at Chapel Hill NATARAJAN, MEERA 1643 §103 Non-Final OA — Pending Dec 21, 2021
17620938 PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY Aker Biomarine Antarctic AS REILLY, SOPHIA JANE 1627 §103DPOther Final Rejection — Pending Dec 20, 2021
17619076 SODIUM THIOSULFATE GEL FOR PREVENTING OR REDUCING HEARING LOSS Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis WEBB, WALTER E 1612 §103 Final Rejection 12d Pending Dec 14, 2021
17549028 PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE The Regents of the University of Michigan ZHU, JIANJIAN 1631 §103§112 Non-Final OA 44d overdue Pending Dec 13, 2021
17611042 HIGH-DENSITY MICROCHANNELS Spiderwort Inc. ROGERS, ERIC JASON 1638 §101§102§103§112DP Final Rejection 19d overdue Pending Nov 12, 2021
17609957 INDUCED HUMAN COLITIC ORGANOIDS The Cleveland Clinic Foundation ROGERS, ERIC JASON 1638 §103§112 Final Rejection — Pending Nov 09, 2021
17517084 TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA The University of Chicago HINES, JANA A 1645 §103 Final Rejection — Pending Nov 02, 2021
17602627 CONTINUOUS TREATMENT WITH PLASMA Fixed Phage Limited KITT, STEPHEN A 1717 §103 Final Rejection — Pending Oct 08, 2021
17491761 MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Crispr Therapeutics AG VIJAYARAGHAVAN, JAGAMYA NMN 1633 §103Other Non-Final OA 80d overdue Pending Oct 01, 2021
17436256 NUCLEIC ACID CONSTRUCT ENCODING Trk FRAGMENT AND USE THEREOF Tokyo Metropolitan Institute Of Medical Science WANG, CHANG YU 1675 §103 Final Rejection 28d Pending Sep 03, 2021
17432849 PHARMACEUTICAL, PHYTO-CANNABINOID BASED COMPOSITIONS Liv Innovation SA LEE, CHIHYI NMN 1628 §101§103§112DP Final Rejection — Pending Aug 20, 2021
17423602 A METHOD FOR TREATING CANCER WITH IMMUNOGLOBULIN E (IGE) King'S College London DENT, ALANA HARRIS 1643 §103 Final Rejection — Pending Jul 16, 2021
17423198 HIGH LOAD DISPERSIONS AND USES THEREOF Austin Research Labs Corp. BAUER, NICOLA MARIA 1621 §103 Final Rejection — Pending Jul 15, 2021
17421677 RAPID REVERSE TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION Northwestern University GIAMMONA, FRANCESCA FILIPPA 1681 §103§112 Final Rejection 30d overdue Pending Jul 08, 2021
17337274 PROGRAMMABLE ARRAYS Engineering Arts LLC SCHLOOP, ALLISON ELIZABETH 1683 §103§112 Non-Final OA 49d Pending Jun 02, 2021
17295414 PRODUCTION OF IMMOBILISED BACTERIOPHAGE Fixed Phage Limited SALVOZA, M FRANCO G 1672 §112 Non-Final OA 42d overdue Pending May 19, 2021
17244136 COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS The Trustees of Columbia University in the City of New York NICOL, ALEXANDER W 1634 DP Non-Final OA — Pending Apr 29, 2021
17286532 USE OF EGG CELLULAR EXTRACT FOR WOUND HEALING Regenics AS TRAN, KHOA NHAT 1632 §103 Non-Final OA 54d Pending Apr 19, 2021
17286276 COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES BAYER AKTIENGESELLSCHAFT EBBINGHAUS, BRIANA NOEL 1632 §103§112Other Final Rejection — Pending Apr 16, 2021
17285825 METHODS FOR DIGITAL MULTIPLEXING OF NUCLEIC ACIDS IN SITU Advanced Cell Diagnostics, Inc. LU, FRANK WEI MIN 1683 §112 Non-Final OA 5d Pending Apr 15, 2021
17284040 NUCLEIC ACID TO ACTIVATE GENE EXPRESSION AND PROTEIN PRODUCTION Ibmc - Instituto De Biologia Molecular E Celular MARVICH, MARIA 1634 §103 Non-Final OA — Pending Apr 09, 2021
17281025 COMPOSITIONS AND METHODS FOR DRUG DELIVERY North Carolina State University STONEBRAKER, ALYSSA RAE 1642 §103Other Final Rejection 27d Pending Mar 29, 2021
17266897 TRI-PEPTIDES AND TREATMENT OF METABOLIC, CARDIOVASCULAR AND INFLAMMATORY DISORDERS The Regents of the University of Michigan DABKOWSKI, ERINNE R 1654 §103DP Final Rejection 2d overdue Pending Feb 08, 2021
17259601 INTRAMOLECULAR KINETIC PROBES The Regents of the University of Michigan NGUYEN, NAM P 1678 §103DP Final Rejection — Pending Jan 12, 2021
17254757 PROCESS FOR PRODUCING BETA-LACTOGLOBULIN ISOLATES AND RELATED METHODS AND USES Arla Foods Amba TRAN, LIEN THUY 1793 §103 Non-Final OA — Pending Dec 21, 2020
17254732 INSTANT BEVERAGE POWDER BASED ON BLG Arla Foods Amba KIM, BRYAN 1792 §103 Non-Final OA — Pending Dec 21, 2020
17254759 ACIDIC BETA-LACTOGLOBULIN BEVERAGE PREPARATION Arla Foods Amba DUBOIS, PHILIP A 1791 §103 Final Rejection 36d overdue Pending Dec 21, 2020
17096131 SYSTEMS AND METHODS FOR SELF-GUIDED INJURY TREATMENT Md Ortho Systems LLC ANJARIA, SHREYA PARAG 3796 §101 Non-Final OA — Pending Nov 12, 2020
17050988 COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES Ilc Therapeutics Ltd. HOLTZMAN, KATHERINE ANN 1646 §103§112 Final Rejection 23d Pending Oct 27, 2020
17074343 SYSTEMS AND METHODS FOR UNTARGETED METABOLOMIC SCREENING Northwestern University PLAYER, ROBERT AUSTIN 1686 §101§103 Final Rejection — Pending Oct 19, 2020
16978048 TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS AND A CDK4/6 INHIBITOR Klinikum Rechts Der Isar Der Technischen Universität München YAMASAKI, ROBERT J 1657 §103Other Final Rejection — Pending Sep 03, 2020
16634820 COMPOSITION FOR CRYOPRESERVATION, METHOD FOR PRODUCING CRYOPRESERVED MATERIAL, CELL PREPARATION, METHOD FOR PRODUCING CELL PREPARATION, AND KIT FOR CRYOPRESERVATION Two Cells Co., Ltd. VAN BUREN, LAUREN K 1638 §103§112 Non-Final OA 24d overdue Pending Jan 28, 2020
16773540 MATERIALS AND METHODS FOR GENE DELIVERY IN THE HEART Northwestern University CRAIG, KAILA ANGELIQUE 1618 §103 Non-Final OA 72d Pending Jan 27, 2020
16596495 COMPOSITIONS AND METHODS FOR OBTAINING STEM CELL DERIVED LUNG TISSUE, AND RELATED USES THEROF The Regents of the University of Michigan SCHUBERG, LAURA J 1631 §103 Non-Final OA 27d Pending Oct 08, 2019
14882913 METHODS AND COMPOSITIONS FOR WOUND HEALING Imbed Biosciences, Inc. VANHORN, ABIGAIL LOUISE 1636 §103 Final Rejection 12d Pending Oct 14, 2015

Managing Casimir Jones, S.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month